Cancer Research Horizons
@crhorizons.bsky.social
260 followers 57 following 33 posts
We are Cancer Research UK's #innovation arm. We strengthen #academia & #industry collaboration, bridging the gap between research and the market.
Posts Media Videos Starter Packs
crhorizons.bsky.social
@goshcharity.bsky.social brings deep-rooted expertise, influential networks and strategic reach to the consortium – helping to grow C-Further’s impact and identify and fund new therapeutic opportunities.

🔗 Read more: bit.ly/4npqMA2

2/
A quote reads: "GOSH Charity's renowned expertise, global network, and deep ties to patients will position C-Further to better collaborate on systemic challenges and improve outcomes for children and young people with cancer" - David Jenkinson, Head of childhood cancer, LifeArc
crhorizons.bsky.social
🚨 We’re proud to welcome @goshcharity.bsky.social as a core partner in #CFurther, joining us and @lifearc.bsky.social in a £37m international effort to transform childhood cancer treatment.

GOSH Charity’s £10m commitment is its largest to date.

🔗 Read more: bit.ly/4npqMA2
1/
A quote reads: "we want to do everything we can to give children the best chance, and best childhood possible" - Aoife Regan, Director of impact and charitable programmes at GOSH Charity.
crhorizons.bsky.social
“Innovation is not an option; it’s a necessity.”
Dame Anna Dominiczak, Chief Scientist (Health), The Scottish Government

We’re excited to welcome the innovation and entrepreneurial community back this November for #InnovationSummit2025.

📅 18 November
📍 London
🔗RSVP: bit.ly/466wotD
crhorizons.bsky.social
Our #InnovationSummit2025 is coming to #London on 18 November 🚀

Join cancer researchers, entrepreneurs, and industry leaders to explore how to turn your discoveries into real-world impact.

💡 Learn from founders
🤝 Build your network
🎯 Explore translational pathways

Get your ticket: bit.ly/466wotD
crhorizons.bsky.social
A huge thank you to all #IEAwards25 winners and nominees for an inspiring evening. We can’t wait to see what’s next on your horizon.

Read more: bit.ly/44m94a0

#OnMyHorizon @anton-henssen.bsky.social, @nnennayakanu.bsky.social, @michellecruk.bsky.social @timwitney.bsky.social, @cuh.nhs.uk
crhorizons.bsky.social
🔬 Could ecDNA be a key to tackling aggressive cancers?

At our first On the Horizon event, experts from @cancergrand.bsky.social and Boundless Bio explored how ecDNA drives tumour evolution, and how it’s now being targeted in the clinic.

More: tinyurl.com/mrhzn894
@ucl.ac.uk #OnMyHorizon
crhorizons.bsky.social
🎉 Congrats to our scientists at The Scotland Institute on their publication in the Journal of Medicinal Chemistry!

They’ve developed reversible Ras inhibitors with tunable affinity for active & inactive forms, a big step in #DrugDiscovery.

More: tinyurl.com/y45t4yy7
#OnMyHorizon @acs.org
crhorizons.bsky.social
Proud to be part of the 3rd EWOC Europe Conference, a fantastic space for connection, growth and championing gender diversity in #chemistry.
Shout-out to @katherine-hazel.bsky.social for helping shape the event as part of the organising team!

Learn more: bit.ly/3V6FBee

#OnMyHorizon #EWOCEU25
crhorizons.bsky.social
Mentorship is powerful. Today we launch our Broadening Horizons programme at @wellcometrust.bsky.social !

We've heard from past mentors and now head to breakout sessions and networking. Thanks to everyone joining us in person and online! #OnMyHorizon

@juliana-c.bsky.social
crhorizons.bsky.social
It was great to hear from our CEO at #AACR2025 about how we can develop more effective, targeted therapeutics for children and young people with cancer, bringing more cures to clinic.

Learn more about #CFurther, our consortium with #LifeArc for #CYP cancers: www.c-further.org
cancerresearchuk.org
This evening it’s the Pediatric Cancer Working Group town hall.

Iain Foulkes will talk about ways to rethink and reshape drug development for children and young people's cancers.

Come along to collaborate, share insights and chart ways forward to drive progress.

#AACR2025 @crhorizons.bsky.social
#AACR25 Town Hall Meeting: Iain Fouled Cancer Research UK
crhorizons.bsky.social
After losing both parents to cancer, Pat LoRusso helped get 26 treatments approved and became #AACR president for 2024/25.

Read her thoughts on her career, #AACR25 and leading @cancerresearchuk.org 's New Agents Committee 👉 bit.ly/44thT21

@theaacr.bsky.social, @yalecancer.bsky.social, @yale.edu
crhorizons.bsky.social
Tackling childhood cancer takes strong partnerships 💪

In the latest “Partnerships to beat cancer” episode, we explore how #CFurther, our consortium for children and young people's cancers with #LifeArc, is driving innovation in this space.

🎧 Tune in: bit.ly/4lsJC9i
Podcast promo for Cancer Research Horizons: “Partnerships to beat cancer.” Episode 6 features Curtis Asante and Matt Ashenden discussing how C-Further is driving innovation for childhood cancer. Includes a “Listen now” button and microphone icon.
crhorizons.bsky.social
Calling all #CancerResearchers: the OncoStars programme, designed to support you in commercialising your research, is open for applications. Apply by 16 May for:

💡 Entrepreneurial training
🤝 Workshops, seminars and mentoring
🌐 Access to professional networks

Apply 👉: tinyurl.com/mr4672de
OncoStars ⋆ Panacea Stars
A PanaceaStars-CRUK partnership to support academics and entrepreneurs translating their groundbreaking science to diagnose, treat and prevent cancer!
tinyurl.com
crhorizons.bsky.social
What’s the best way to mimic the tumour microenvironment for drug discovery?

📰 In this Technology Networks article, Dave Kim, senior scientist at the Functional Genomics Centre, explores the pros and cons of different cell culture models, from cell lines to organoids.

Read more 👉 bit.ly/4jcV9aL
 A quote card featuring a statement from Dave Kim, Senior Scientist at the Functional Genomics Centre. The quote reads: "We would be able to build more sophisticated models that can reduce the gap between lab research and clinical application – making cancer treatments more effective and accessible." Below the quote is a headshot of Dave Kim, a man in a suit, smiling. The Cancer Research Horizons logo is displayed in the bottom right corner.
crhorizons.bsky.social
A great mentor can transform your #TranslationalResearch journey 🚀

We're excited to once again bring you the Broadening Horizons mentorship programme. Gain skills to make an impact beyond the lab with:

🤝 Expert mentors
🧠 Engaging events
💡 Inspiring talks

Apply by 30 April: bit.ly/3FUiYpf
crhorizons.bsky.social
Deadline extended 🚨 One more week to nominate for our #IEAwards25 👉https://bit.ly/4bejj1H

Boost your #TranslationalResearch project with up to £15K in #Funding, access to industry connections and showcase your work at our Awards ceremony.

Deadline: 24 March: #OnMyHorizon
crhorizons.bsky.social
🚨 Nominations for our #IEAwards25 close on 17 March!

If you're driving #TranslationalResearch, this is your chance to boost your project, gain funding & connect with industry leaders.

⏳Nominate yourself or a peer now: bit.ly/3CVCD7c

#OnMyHorizon
crhorizons.bsky.social
Know a woman entrepreneur turning ideas into patient benefit? Nominate her for our #IEAwards25 👉 bit.ly/429ofCN - only two weeks left!

Winners will receive:
💡 £5,000
🤝 Access to other entrepreneurs, industry experts and investors

Nominate yourself or a peer by 17 March ⏲

#OnMyHorizon
Innovation and Entrepreneurship Awards
Our Awards celebrate researchers who are transforming ground-breaking discoveries into patient benefit. By spotlighting exceptional talent and ambition, we aim to inspire a new generation of innovator...
bit.ly
crhorizons.bsky.social
On #RareDiseaseDay, we look back at the achievements of our rare cancer trial DETERMINE.

DETERMINE is managed by the Centre for Drug Development, in partnership with @official-uom.bsky.social m.bsky.social, @unibirmingham.bsky.social and the Royal Marsden.

Read more 👉 bit.ly/3D9axpk
crhorizons.bsky.social
We're celebrating entrepreneurial researchers turning groundbreaking discoveries into patient benefit through our #IEAwards25 🏆 Is that you, or someone who inspires you?

Nominations close 17th March. Nominate yourself or a peer now 👉 bit.ly/3CVCD7c

#OnMyHorizon
crhorizons.bsky.social
Our key takeaways from #JPM2025:

🤝 M&As rise

🤖 #AI boosts drug discovery

🌎 Chinese #Innovation gains global recognition

Discover more insights 👉 bit.ly/4htaweG

#HealthcareInnovation, #AI, #OnMyHorizon
crhorizons.bsky.social
Thinking of submitting your #PediatricOncology project to #CFurther on 2 March?

Watch our on-demand webinar to discover what projects are in demand and how to craft a successful application.

Watch here: bit.ly/4hNX8BG

#OnMyHorizon
crhorizons.bsky.social
4 biotech leaders, 4 women, 4 stories.

To mark International Day of Women and Girls in Science, they share their journeys of co-founding and leading cutting-edge oncology start-ups while ensure the path to success is open to everyone 💡 bit.ly/42PF6KY

#OnMyHorizon #WomenInScience
crhorizons.bsky.social
Our new podcast, 'Partnerships to beat cancer', is all about the power of collaboration 💪

Listen to the first 2 episodes 👉 bit.ly/3ClY3dx and learn how we collaborate with commercial and academic partners to take on the challenges that no one else can.

#OnMyHorizon #ASAPCommunity
crhorizons.bsky.social
Apply by 13 January 🚨

Attention #PaediatricOncology researchers: our Translational Medicine Certificate Course offers interactive sessions, personalised mentoring and #sponsorship for up to 7 researchers.

Contact us to apply: [email protected]
#OnMyHorizon